CA Patent

CA2419573C — Method of increasing testosterone and related steroid concentrations in women

Assigned to Unimed Pharmaceuticals LLC · Expires 2007-04-03 · 19y expired

What this patent protects

The present invention relates to methods, kits, combinations, and compositio ns for treating, preventing or reducing the risk of developing a testosterone deficient disorder, or the symptoms associated with, or related to a testosterone deficient disorder in a female mammal in ne…

USPTO Abstract

The present invention relates to methods, kits, combinations, and compositio ns for treating, preventing or reducing the risk of developing a testosterone deficient disorder, or the symptoms associated with, or related to a testosterone deficient disorder in a female mammal in need thereof. The present invention also relates to a method of administering a steroid in the testosterone synthetic pathway, for example testosterone, to a mammal in nee d thereof. In addition, the methods, kits, combinations and compositions may b e used in conjunction with other pharmaceutical agents effective at treating, preventing, or reducing the risk of developing a testosterone deficient disorder. The methods, kits, combinations and compositions can also be used in conjunction with a pharmacologically effective amount of an estrogenic hormone, for example, estradiol. Furthermore, the methods, kits, combination s and compositions can be used in conjunction with a pharmacologically effecti ve amount of another steroid or pharmaceutical agent that increases serum testosterone levels in a mammal, for example, methyltestosterone.

Drugs covered by this patent

Patent Metadata

Patent number
CA2419573C
Jurisdiction
CA
Classification
Expires
2007-04-03
Drug substance claim
No
Drug product claim
No
Assignee
Unimed Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.